Formal Total Synthesis of Ovalcin by Carbohydrate Approach

Abstract

A formal total synthesis of ovalcin is described herein starting from readily available sugar ribose with selective zinc-mediated ring-opening reaction and Grubbs olefin metathesis as the key steps.

Key words

angiogenesis - metathesis - ring opening - epoxidation

References and Notes

• 1a Hanahan D. Folkman J. Cell  1996,  86:  353 
• 1b Folkman J. Nature Med.  1995,  1:  27 
• 1c Folkman J. Klagsbrun M. Science  1987,  235:  442 
• 2a Powell D. Skotnicki J. Upeslacis J. Annu. Rep. Med. Chem.  1997,  32:  161 
• 2b Giannis A. Rübsam F. Angew. Chem., Int. Ed. Engl.  1997,  36:  588 
• 2c Auerbach W. Auerbach R. Pharmacol. Ther.  1994,  63:  265 
• 2d Folkman JN. Engl. J. Med.  1971,  285:  1182 
• 3a Killough JH. Magill GB. Smith RC. Science  1952,  115:  71 
• 3b Katznelson H. Jamieson CA. Science  1952,  115:  70 
• 3c McCowen MC. Callender ME. Lawlis JF. Science  1951,  113:  202 
• 3d Eble TE. Hanson FR. Antibiot. Chemother.  1951,  1:  54 
• 4a Logothetis CJ. Wu KK. Finn LD. Daliani D. Figg W. Ghaddar H. Gutterman JU. Clin. Cancer Res.  2001,  7:  1198 
• 4b Stadler WM. Kuzel T. Shapiro C. Sosman J. Clark J. Vogelzang NJ. J. Clin. Oncol.  1999,  17:  2541 
• 4c Dezube BJ. Von Roenn JH. Holden-Wiltse J. Cheung TW. Remick SC. Coolwy TP. Moore J. Sommadossi JP. Shriver SL. Suckown CW. Gill PS. J. Clin. Oncol.  1998,  16:  1444 
• 4d Marui S. Itoh F. Kozai Y. Sudo K. Kishimoto S. Chem. Pharm. Bull.  1992,  40:  96 
• 4e Ingber D. Fujita T. Kishimoto S. Sudo K. Kanamaru T. Brem H. Folkman J. Nature (London)  1990,  348:  555 
• 5a Sigg HP. Weber HP. Helv. Chim. Acta  1968,  51:  1395 
• 5b Sassa T. Kaise H. Munakata K. Agric. Biol. Chem.  1970,  34:  649 
• 5c Bollinger P. Sigg HP. Weber HP. Helv. Chim. Acta  1973,  56:  78 
• 6a Corey EJ. Dittami JP. J. Am. Chem. Soc.  1985,  107:  256 
• 6b Corey EJ. Guzman-Perez A. Noe MC. J. Am. Chem. Soc.  1994,  116:  12109 
• 7a Barco A. Benetti S. De Risi C. Marchetti P. Pollini GP. Zanirato V. Tetrahedron: Asymmetry  1998,  9:  2857 
• 7b Barton DHR. Bath S. Billington DC. Gero SD. Quiclet-Sire B. Samadi M. J. Chem. Soc., Perkin Trans. 1  1995,  1551 
• 7c Bath S. Billington DC. Gero SD. Quiclet-Sire B. Samadi M. J. Chem. Soc., Chem. Commun.  1994,  1495 
• For recent works, see:
• 8a Yadav JS. Prathap I. Tadi BP. Tetrahedron Lett.  2006,  47:  3773 
• 8b Yadav JS. Srinivas R. Sathaiah K. Tetrahedron Lett.  2006,  47:  1603 
• 8c Yadav JS. Raju AK. Rao PP. Rajaiah G. Tetrahedron: Asymmetry  2005,  16:  3283 
• 8d Yadav JS. Prakash SJ. Gangadhar Y. Tetrahedron: Asymmetry  2005,  16:  2722 
• 8e Yadav JS. Reddy MS. Prasad AR. Tetrahedron Lett.  2005,  46:  2133 
• 9 Fréchou C. Dheilly L. Beaupère D. Uzan R. Demailly G. Tetrahedron Lett.  1992,  33:  5067 
• 10 Garegg J. Samuelsson B. J. Chem. Soc., Perkin Trans. 1  1980,  2866 
• 11a Bernet B. Vasella A. Helv. Chim. Acta  1979,  62:  1990 
• For applications and modified procedures, see:
• 11b Ferrier RJ. Furneaux RH. Prasit P. Tyler PC. Brown KL. Gainsford GJ. Diehl W. J. Chem. Soc., Perkin Trans. 1  1983,  1621 
• 11c Ferrier RJ. Prasit P. J. Chem. Soc., Perkin Trans. 1  1983,  1645 
• 11d Ferrier RJ. Schmidt P. Tyler PC. J. Chem. Soc., Perkin Trans. 1  1985,  301 
• 11e Nicolaou KC. Duggan ME. Ladduwahetty T. Tetrahedron Lett.  1984,  25:  2069 
• 11f Yadav JS. Reddy BVS. Srinivasa Reddy K. Tetrahedron  2003,  59:  5333 
• 12a Omura K. Swern D. Tetrahedron  1978,  34:  1651 
• 12b Mancuso AJ. Brownfain DS. Swern D. J. Org. Chem.  1979,  44:  4148 
• 12c Mancuso AJ. Huang SL. Swern D. J. Org. Chem.  1978,  43:  2480 
• 13 Hyldtoft L. Madsen R. J. Am. Chem. Soc.  2000,  122:  8444 

14

Selected Spectroscopic Data
Compound 4: colorless oil; [α]_D -57 (c 2.1 CHCl₃), lit [7b] [α]_D -60.0 (c 1.28, CHCl₃). IR (CHCl₃): 3458, 1452, 1380, 1247, 1114, 1014, 981 cm^-1. ¹H NMR (300 MHz, CDCl₃): δ = 4.30 (s, 1 H), 4.02 (d, J = 9.0 Hz, 1 H), 3.44 (s, 3 H), 3.06 (d, J = 4.5 Hz, 1 H), 3.03 (d, J = 2.2 Hz, 1 H), 2.57 (d, J = 5.2 Hz, 1 H), 2.23 (td, J = 5.4 Hz, 1 H), 1.99 (br s, 1 H, OH), 1.73 (m, 2 H), 1.35 (m, 1 H), 0.97 (t, 9 H), 0.61 (q, 6 H). ¹³C NMR (75 MHz, CDCl₃): δ = 85.23, 67.52, 66.76, 59.95, 57.71, 50.06, 28.90, 26.20, 6.74, 4.88. MS-FAB: m/z = 260 [M⁺].
Compound 11: colorless oil; [α]_D -13.0 (c 2.5, CHCl₃). IR (CHCl₃): 3476, 2934, 1613, 1514, 1458, 1301, 1173, 931, 758 cm^-1. ¹H NMR (200 MHz, CDCI₃): δ = 7.22 (d, J = 8.5 Hz, 2 H), 6.82 (d, J = 8.5 Hz, 2 H), 5.96 (m, 1 H), 5.24 (m, 2 H), 4.51 (m, 1 H), 4.43 (d, J = 1.5 Hz, 2 H), 4.17 (dd, J = 3.1, 7.0 Hz, 1 H), 3.77 (s, 1 H), 3.66 (m, 1 H), 3.40 (d, J = 5.4 Hz, 1 H), 2.17 (d, J = 5.4 Hz, 1 H), 1.48 (s, 3 H), 1.35 (s, 3 H). ¹³C NMR (75 MHz, CDCl₃): δ = 159.30, 134.08, 130.00, 129.40, 119.45, 113.80, 108.67, 79.01, 68.76, 52.24, 27.18, 24.95. MS-FAB: m/z = 308 [M⁺].